Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported beneficial ownership of 8.3% of Lifestance Health Group Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 14.9% in ManpowerGroup Inc. as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 5.6% in MasterCraft Boat Holdings Inc. as of June 30, 2026.

BlackRock Inc. has disclosed a beneficial ownership of 1.3% in Maxcyte, Inc. as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.7% in McEwen Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an updated Schedule 13G, reporting beneficial ownership of 327,404 shares of Medifast Inc. common stock, representing 2.9% of the class.

BlackRock, Inc. has reported a beneficial ownership of 5.8% in MetroCity Bankshares Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.1% in Miami International Holdings Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.3% in Mission Produce, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 3,408,529 shares, representing 6.5% of the outstanding common stock of Nano Nuclear Energy Inc.

BlackRock, Inc. has reported beneficial ownership of 8.1% of nCino, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 11.9% of Nextpower Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.0% in Ocular Therapeutix, Inc., holding over 15.2 million shares.

BlackRock, Inc. has reported beneficial ownership of 8.0% of Ocugen, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 7.1% of Olema Pharmaceuticals, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.2% in Ondas Holdings Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 2.3% of OppFi Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of OptimizeRx Corp. common stock.

BlackRock, Inc. has disclosed a beneficial ownership of 8.8% of Liberty Latin America Ltd.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 9,013,741 shares, representing 6.2% of the outstanding common stock of Niocorp Developments Ltd.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 12.7% of Allegiant Travel Company's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in GeneDx Holdings Corp. Class A Stock, as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.0% in JFrog Ltd., holding over 7.3 million shares.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 26,229,501 shares, representing 16.2% of DXC Technology Co.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.3% of Eagle Financial Services Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.7% in EyePoint Pharmaceuticals, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.3% of FIGS, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.9% of First Advantage Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.6% of First National Corp's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership stake of 5.9% in First United Corp, holding 378,880 shares.